Population and individual strategies for the prevention of XXXX . Policy of the @entity731 Society.

@entity1 @entity301 @entity412 @entity731 @entity65 @entity165
@entity301 ( @entity301 ) risk factors affect a large proportion of European adult populations; hence most @entity301 results from the exposure of many @entity1 to moderately elevated risk factor levels. The population strategy is directed to improving the health-related behaviour of the entire population, by means of mass education and administrative measures aimed at nutrition, smoking and exercise; these measures are reviewed in some detail. This approach is inadequate for minimising risk in the minority in whom pronounced risk factor levels are present (e.g. major forms of hyperlipidaemia); such @entity1 require individual therapy in a clinical setting, i.e. an individual strategy. The @entity731 Society (EAS) endorses both strategies and regards them as complementary. It advocates a case-finding approach to identifying those @entity1 requiring individual care. Although lipid risk factors, like blood pressure, are continuous variables, the EAS has defined action limits for plasma @entity165 , @entity412 and HDL- @entity165 concentrations; the interpretation of these is influenced by the presence and extent of other risk factors and of @entity65 , and by age and sex. Recently the EAS has produced guidelines on the recognition and treatment of hyperlipidaemia. These provide sufficient step by step detail to permit the effective, safe management of most hyperlipidaemic @entity1 by the non-specialised physician, with advice on dietary and drug therapies, and the investigation and management of all major forms of hyperlipidaemia. The main features of these guidelines are described in this paper.
